source
- Former FDA commissioner sees hope for stability under new acting leader Kyle DiamantasAt a recent STAT Breakthrough Summit West, former FDA commissioner David Kessler addressed concerns about the agency’s recent turmoil and staff departures. Kessler said the appointment of acting c…
- Relay Therapeutics reports promising Phase 2 results for zovegalisib; Eli Lilly leads R&D performance rankingRelay Therapeutics announced positive Phase 2 data for its experimental drug zovegalisib, which targets rare diseases that cause abnormal blood vessel development. The company said the results were…